Hirotoshi Ichibori

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium

Atsushi Suzuki, Koji Fukuzawa, Tomoya Yamashita et al. · EP Europace · 2016 · 45 citations · Full text

Veterinary Medicine, Cardiology, Immunology +15

The lesion characteristics assessed by <scp>LGE</scp>‐<scp>MRI</scp> after the cryoballoon ablation and conventional radiofrequency ablation

Jun Kurose, Kunihiko Kiuchi, Koji Fukuzawa et al. · Journal of Arrhythmia · 2018 · 31 citations · Full text

Medicine, Cardiology, Surgery +9

Trans‐aortic pulmonary vein isolation using magnetic navigation system for paroxysmal atrial fibrillation in a patient with dextrocardia, situs inversus, and inferior vena cava continuity with azygos vein

Katsunori Okajima, Tomoyuki Nakanishi, Hirotoshi Ichibori et al. · Journal of Arrhythmia · 2018 · 17 citations · Full text

Medicine, Cardiology, Surgery +13

Visualization of the Antegrade Fast and Slow Pathway Inputs in Patients with Slow‐Fast Atrioventricular Nodal Reentrant Tachycardia

Atsushi Suzuki, Akihiro Yoshida, Asumi Takei et al. · Pacing and Clinical Electrophysiology · 2014 · 12 citations · Full text

Medicine, Anatomy, Cardiology +14